
BIOLOGICAL TESTING PRODUCTS COMPANY LMNX BECOMES A BUYOUT TARGET
Luminex Corporation (LMNX) has become a buyout target. There is an 80% probability of a deal ultimately happening. LMNX is trading at $32.09 as of this writing. The most likely acceptable bid is in the zone of $38 to $42. If a bidding war erupts, the stock can go higher. In the world of investing there no free lunch. The issue here is that the stock can easily trade in the range of $21 to $34 in the interim. A good way to handle this situation is to scale in with small tranches such as 5%. The maximum recommended quantity